Index RUT
P/E 61.95
EPS (ttm) 0.49
Insider Own 18.18%
Shs Outstand 20.05M
Perf Week -4.64%
Market Cap 608.94M
Forward P/E 25.71
EPS next Y 1.18
Insider Trans -3.26%
Shs Float 16.42M
Perf Month 6.10%
Income 9.95M
PEG 4.13
EPS next Q 0.14
Inst Own 77.21%
Short Float 6.03%
Perf Quarter -12.04%
Sales 70.01M
P/S 8.70
EPS this Y 90.14%
Inst Trans -4.14%
Short Ratio 5.00
Perf Half Y -35.37%
Book/sh 9.10
P/B 3.34
EPS next Y 17.14%
ROA 4.97%
Short Interest 0.99M
Perf Year -22.03%
Cash/sh 1.01
P/C 30.07
EPS next 5Y 15.00%
ROE 5.65%
52W Range 27.07 - 51.22
Perf YTD -32.19%
Dividend Est. -
P/FCF 47.76
EPS past 5Y 0.62%
ROI 5.44%
52W High -40.76%
Beta 0.77
Dividend TTM 0.18 (0.59%)
Quick Ratio 3.26
Sales past 5Y 15.64%
Gross Margin 61.63%
52W Low 12.12%
ATR (14) 1.29
Dividend Ex-Date Jul 29, 2024
Current Ratio 3.26
EPS Y/Y TTM 0.34%
Oper. Margin 8.76%
RSI (14) 47.50
Volatility 2.92% 4.33%
Employees 247
Debt/Eq 0.01
Sales Y/Y TTM 17.52%
Profit Margin 14.22%
Recom 1.29
Target Price 50.00
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 56.72%
Payout 48.95%
Rel Volume 0.24
Prev Close 31.12
Sales Surprise -5.24%
EPS Surprise 21.95%
Sales Q/Q 19.42%
Earnings Oct 23 AMC
Avg Volume 197.90K
Price 30.34
SMA20 -1.02%
SMA50 -1.51%
SMA200 -23.07%
Trades
Volume 8,069
Change -2.49%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-15-24 Initiated
Stephens
Overweight
$39
Jul-29-24 Initiated
KeyBanc Capital Markets
Overweight
$47
Jul-16-24 Initiated
JMP Securities
Mkt Perform
Jun-28-24 Initiated
William Blair
Outperform
May-09-23 Initiated
BTIG Research
Buy
$55
Oct-26-21 Upgrade
Craig Hallum
Hold → Buy
$65 → $53
Jan-12-21 Downgrade
Craig Hallum
Buy → Hold
Oct-16-20 Initiated
Raymond James
Outperform
$95
Sep-08-20 Initiated
Oppenheimer
Outperform
$79
Jan-06-20 Initiated
Craig Hallum
Buy
$40
Nov-26-24 09:55AM
Nov-22-24 07:15AM
Nov-19-24 08:30AM
Nov-13-24 08:30AM
Nov-08-24 09:55AM
08:30AM
Loading…
Nov-06-24 08:30AM
Oct-30-24 08:30AM
Oct-24-24 10:52AM
(Thomson Reuters StreetEvents) -8.89%
03:10AM
Oct-23-24 06:05PM
05:17PM
(Associated Press Finance)
04:06PM
Oct-22-24 08:49AM
Oct-09-24 04:06PM
Oct-08-24 08:30AM
10:28AM
Loading…
Oct-01-24 10:28AM
Sep-04-24 07:00PM
Aug-28-24 08:30AM
Aug-26-24 11:00AM
Aug-23-24 08:00AM
Aug-16-24 02:48AM
Aug-09-24 09:23AM
Aug-02-24 11:34PM
Aug-01-24 08:30AM
Jul-30-24 08:30AM
Jul-25-24 08:30AM
Jul-20-24 09:25AM
Jul-12-24 10:07AM
Jul-11-24 08:30AM
Jul-03-24 10:20AM
09:29AM
Loading…
09:29AM
(Thomson Reuters StreetEvents)
08:02AM
Jul-02-24 08:52PM
04:16PM
(Associated Press Finance)
04:06PM
Jun-25-24 10:00AM
Jun-20-24 08:30AM
Jun-18-24 08:30AM
Jun-14-24 12:00PM
Jun-13-24 09:10AM
Jun-12-24 08:58AM
08:00AM
Jun-04-24 07:00PM
May-22-24 08:30AM
May-16-24 01:18PM
May-15-24 07:01PM
08:30AM
May-08-24 09:15PM
May-03-24 02:28AM
Apr-12-24 01:53PM
Apr-08-24 09:06AM
Apr-04-24 09:27AM
08:30AM
06:34AM
06:24AM
(Thomson Reuters StreetEvents)
Apr-03-24 08:53PM
05:32PM
05:20PM
04:34PM
04:21PM
(Associated Press Finance)
Apr-02-24 07:24AM
Mar-20-24 04:06PM
Mar-13-24 08:30AM
Mar-05-24 05:01PM
08:30AM
Feb-23-24 05:14AM
Feb-15-24 08:30AM
Feb-13-24 09:15AM
Feb-06-24 08:30AM
Feb-05-24 11:30PM
09:35AM
Jan-30-24 08:30AM
Jan-11-24 09:55AM
Jan-09-24 08:30AM
Jan-05-24 03:02AM
Jan-04-24 08:42AM
06:54AM
(Thomson Reuters StreetEvents)
Jan-03-24 11:26PM
09:51PM
04:13PM
(Associated Press Finance)
04:06PM
04:05PM
Jan-02-24 05:27PM
Dec-29-23 08:55AM
Dec-20-23 08:30AM
Dec-06-23 03:04AM
Nov-14-23 08:00AM
Nov-08-23 08:30AM
Nov-03-23 07:03PM
Oct-31-23 08:30AM
Oct-26-23 12:29PM
10:07AM
(Thomson Reuters StreetEvents)
Oct-25-23 06:36PM
05:23PM
(Associated Press Finance)
04:06PM
Oct-11-23 04:06PM
Sep-21-23 08:30AM
Sep-07-23 08:30AM
Aug-24-23 08:30AM
Aug-15-23 08:30AM
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WOLTOSZ WALTER S Director Dec 02 '24 Sale 31.76 20,000 635,200 3,442,584 Dec 03 05:35 PM LaVange Lisa Director Dec 02 '24 Sale 31.88 650 20,722 7,150 Dec 03 05:32 PM LISA LAVANGE Officer Dec 02 '24 Proposed Sale 31.77 650 20,650 Dec 02 04:34 PM WOLTOSZ WALTER S Director Nov 01 '24 Sale 27.66 20,000 553,200 3,462,584 Nov 05 08:02 AM WOLTOSZ WALTER S Director Oct 01 '24 Sale 31.26 20,000 625,200 3,481,592 Oct 02 04:34 PM WEINER DANIEL L Director Sep 27 '24 Sale 31.54 750 23,655 6,994 Oct 01 04:30 PM VIRGINIA EVANS WOLTOSZ & WALTE Director Oct 01 '24 Proposed Sale 32.02 60,000 1,921,200 Oct 01 04:29 PM DANIEL LEE WEINER Director Sep 27 '24 Proposed Sale 31.07 750 23,302 Sep 27 04:24 PM BRETT ALYN HOWELL Officer Sep 18 '24 Proposed Sale 32.00 12,200 390,400 Sep 18 04:17 PM Fiedler-Kelly Jill Business Unit President Sep 09 '24 Option Exercise 9.71 2,250 21,848 68,867 Sep 10 04:45 PM WOLTOSZ WALTER S Director Sep 03 '24 Sale 35.18 20,000 703,677 3,501,592 Sep 04 04:11 PM LaVange Lisa Director Sep 03 '24 Sale 35.95 650 23,368 6,808 Sep 04 04:09 PM LISA LAVANGE Director Sep 03 '24 Proposed Sale 36.25 650 23,562 Sep 03 04:29 PM WOLTOSZ WALTER S Director Aug 01 '24 Sale 39.63 20,000 792,547 3,521,592 Aug 02 04:19 PM WOLTOSZ WALTER S Director Jul 01 '24 Sale 46.71 20,000 934,227 3,540,857 Jul 02 04:10 PM WEINER DANIEL L Director Jun 28 '24 Sale 49.32 750 36,990 7,009 Jul 01 04:24 PM WOLTOSZ WALTER S Director Jun 03 '24 Sale 46.25 20,000 924,978 3,560,857 Jun 04 05:04 PM LaVange Lisa Director Jun 03 '24 Sale 48.26 650 31,369 6,723 Jun 04 05:03 PM LaVange Lisa Director May 14 '24 Sale 50.00 500 25,000 7,373 May 15 04:56 PM WEINER DANIEL L Director May 14 '24 Option Exercise 34.23 2,000 68,460 10,759 May 15 04:53 PM WEINER DANIEL L Director May 14 '24 Sale 50.13 3,000 150,390 7,759 May 15 04:53 PM WEINER DANIEL L Director May 07 '24 Option Exercise 34.23 2,000 68,460 12,009 May 08 04:42 PM WEINER DANIEL L Director May 07 '24 Sale 48.31 3,250 157,008 8,759 May 08 04:42 PM LaVange Lisa Director May 07 '24 Sale 48.30 650 31,395 7,873 May 08 04:39 PM WOLTOSZ WALTER S Director May 01 '24 Sale 45.95 20,000 918,984 3,580,857 May 02 04:37 PM WOLTOSZ WALTER S Director Apr 01 '24 Sale 39.94 20,000 798,867 3,600,195 Apr 02 04:32 PM WOLTOSZ WALTER S Director Mar 01 '24 Sale 41.41 20,000 828,240 3,620,195 Mar 05 04:22 PM WOLTOSZ WALTER S Director Feb 01 '24 Sale 38.02 18,945 720,237 3,641,250 Feb 05 05:04 PM WOLTOSZ WALTER S Director Feb 02 '24 Sale 37.64 1,055 39,710 3,640,195 Feb 05 05:04 PM Paglia John Kenneth Director Jan 04 '24 Sale 43.74 1,000 43,740 2,097 Jan 04 06:37 PM WOLTOSZ WALTER S Director Jan 02 '24 Sale 44.46 20,000 889,200 3,659,403 Jan 04 06:36 PM DiBella John Anthony II Business Unit President Dec 22 '23 Sale 45.16 5,411 244,361 74,429 Dec 26 04:31 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite